Virginia Tech® home

Data-Driven Discovery of Secreted Proteins as Cancer Immunotherapies

Insert your title here

Peng Jiang, Ph.D.

Peng Jiang, Ph.D.

Senior Investigator
National Cancer Institute
National Institutes of Health
Pioneers in Biomedical Research Seminar

Data-Driven Discovery of Secreted Proteins as Cancer Immunotherapies

Date: Oct. 16, 2026

Time: 11 a.m. to noon

In-person: Cancer Research Center — D.C.

Virtual: Join via Zoom

About this Seminar

Dr. Jiang's research focuses on developing data-integration and artificial intelligence frameworks to study intercellular signaling mediated by secreted proteins in antitumor immunity. Data-driven analyses estimate that about two thousand human genes encode secreted proteins. Yet, his lab's literature mining revealed that 61 percent of these genes lack known roles in cancer. To address this gap, Jiang and his team develop computational methods and apply diverse immunological models to dissect cytokine networks, secreted proteins, and ligand–receptor interactions in cancer. Ultimately, his goal is to uncover new mechanisms of immune regulation and identify therapeutic opportunities that harness intercellular communication against tumors.

 

Additional Details

This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Cancer Research Center — D.C. The Pioneers in Biomedical Research Seminar Series, which runs annually from September to May, has featured leading biomedical researchers from throughout the country since the program began in 2012. The lectures are also open to all members of the Virginia Tech community including graduate students, undergraduates, faculty, and staff, as well as the public.

You May Also Be Interested In...

  • Home Item
    Why Measure?
    Why Measure? , home

    Sept. 17, 2026, 5:30 p.m. (Reception at 5 p.m.) | Christopher S. Hourigan, DM, DPhil, FRCP, Professor and Director, Cancer Research Center — D.C., Fralin Biomedical Research Institute | Maury Strauss Distinguished Public Lecture

  • Home Item
    Brown Adipose Tissue as a Mediator of Cardiovascular Health
    Brown Adipose Tissue as a Mediator of Cardiovascular Health , home

    Sept. 18, 2026, 11:00 a.m. | Kristin Stanford, Ph.D., FAHA, Professor, Department of Surgery; William D. and Jacquelyn L. Wells Chair, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Exercise Medicine Research

  • Home Item
    mTor Signaling in Pulmonary Vascular Disease: Bench to Bedside and Back
    mTor Signaling in Pulmonary Vascular Disease: Bench to Bedside and Back , home

    Sept. 25, 2026, 11:00 a.m. | Elena Goncharova, Ph.D., ATSF, FAHA, Professor, Department of Internal Medicine; Director, Pulmonary Vascular Disease Program, UC Davis School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Vascular and Heart Research

  • Home Item
    How Can Research Inform Better Public Policy Towards Addiction?
    How Can Research Inform Better Public Policy Towards Addiction? , home

    Oct. 2, 2026, 11:00 a.m. | Keith Humphreys, OBE, Ph.D., Esther Ting Memorial Professor, Department of Psychiatry, Stanford University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Health Behaviors Research

  • Home Item
    Exercise, the Fountain of Youth?
    Exercise, the Fountain of Youth? , home

    Oct. 15, 2026, 5:30 p.m. (Reception at 5 p.m.) | Zhen Yan, Ph.D., Professor and Director, Center for Exercise Medicine Research, Fralin Biomedical Research Institute at VTC | Maury Strauss Distinguished Public Lecture

  • Home Item
    Data-Driven Discovery of Secreted Proteins as Cancer Immunotherapies
    Data-Driven Discovery of Secreted Proteins as Cancer Immunotherapies , home

    Oct. 16, 2026, 11:00 a.m. | Peng Jiang, Ph.D., Senior Investigator, National Cancer Institute, National Institutes of Health | Co-Sponsored by the Fralin Biomedical Research Institute and the Cancer Research Center — D.C.